CMPX

Compass Therapeutics, Inc.

Contracts

Total Value

Stock Metrics

32.5%

Short % Float

17.6d to cover · High squeeze

88.7%

Inst % Float

10 holders · 2026-06-30

Tang Capital Manag

Top Holder

10.0% of float

122.7M sh

Public Float

38/100

Dilution Score

Medium

38 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

38/100

MEDIUM

Inst: 88.65% · Top: Tang Capital Management, LLC

Biotech Analytics

Biotech / Pharma

50.55

Squeeze risk: HIGH

Insider Buying0

Publications100

Dilution Risk38

Clinical Trials79

Short Interest90